“Vertex Pharmaceuticals (VRTX)… Overall, it appears that Wall Street agrees with Tenthoff. VRTX shares have a Strong Buy analyst consensus rating, based on 14 Buys and 4 Holds. The stock’s $287.50 average price target suggests it has room for 24% growth… Continue Reading…